It was reported that BRMS1 suppression of tumor metastasis is mediated via inhibition of NF-kB and subsequent suppression of the urokinase-type plasminogen activator (uPA) [12], a serine protease that is known to activate the MMPs [13] leading to invasion and metastasis. The gene discussed is BRMS1; the disease is neoplasm.